E49-012

Aglaia Therapeutics

Health

Description

Aglaia Therapeutics is a biopharmaceutical company developing innovative drugs that selectively inhibits key regulators of oncoprotein synthesis to improve the efficiency of anti-cancer targeted therapies and immunotherapies.


Health

© Viva technology, 2017-2019 all rights reserved

App powered by inwink